BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Westwood M, Corro Ramos I, Lang S, Luyendijk M, Zaim R, Stirk L, Al M, Armstrong N, Kleijnen J. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis. Health Technol Assess 2017;21:1-234. [PMID: 28643629 DOI: 10.3310/hta21330] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Chandrapalan S, Bosch S, Cubiella J, Guardiola J, Kimani P, Mulder C, Persaud K, de Meij TGJ, Altomare DF, Brenner H, de Boer NKH, Ricciardiello L, Arasaradnam RP. Systematic review with meta-analysis: volatile organic compound analysis to improve faecal immunochemical testing in the detection of colorectal cancer. Aliment Pharmacol Ther 2021;54:14-23. [PMID: 34004036 DOI: 10.1111/apt.16405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
2 Saw KS, Liu C, Xu W, Varghese C, Parry S, Bissett I. Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis. Br J Surg 2021:znab411. [PMID: 34907419 DOI: 10.1093/bjs/znab411] [Reference Citation Analysis]
3 Fraser CG. Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversies. Gastroenterol Hepatol 2019;42:263-70. [PMID: 30459060 DOI: 10.1016/j.gastrohep.2018.09.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
4 D'Souza N, Abulafi M. The faecal immunochemical test in low risk patients with suspected bowel cancer. Br J Hosp Med (Lond) 2019;80:22-6. [PMID: 30592674 DOI: 10.12968/hmed.2019.80.1.22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
5 Farrugia A, Widlak M, Evans C, Smith SC, Arasaradnam R. Faecal immunochemical testing (FIT) in symptomatic patients: what are we missing? Frontline Gastroenterol 2020;11:28-33. [PMID: 31885837 DOI: 10.1136/flgastro-2018-101174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
6 D'Souza N, Brzezicki A, Abulafi M. Faecal immunochemical testing in general practice. Br J Gen Pract 2019;69:60-1. [PMID: 30704994 DOI: 10.3399/bjgp19X700853] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Pin-Vieito N, Puga M, Fernández-de-Castro D, Cubiella J. Faecal immunochemical test outside colorectal cancer screening? World J Gastroenterol 2021; 27(38): 6415-6429 [PMID: 34720531 DOI: 10.3748/wjg.v27.i38.6415] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Calanzani N, Chang A, Van Melle M, Pannebakker MM, Funston G, Walter FM. Recognising Colorectal Cancer in Primary Care. Adv Ther 2021;38:2732-46. [PMID: 33864597 DOI: 10.1007/s12325-021-01726-6] [Reference Citation Analysis]
9 Tsapournas G, Hellström PM, Cao Y, Olsson LI. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy. Scand J Gastroenterol 2020;55:184-92. [PMID: 31906738 DOI: 10.1080/00365521.2019.1708965] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Sandhu K, Naik S, Ayling RM. Use of faecal immunochemical testing as an alternative to faecal calprotectin in children. Ann Clin Biochem 2021;58:230-5. [PMID: 33412889 DOI: 10.1177/0004563221989359] [Reference Citation Analysis]
11 Navarro M, Hijos G, Sostres C, Lué A, Puente-Lanzarote JJ, Carrera-Lasfuentes P, Lanas A. Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance. Front Med (Lausanne) 2020;7:410. [PMID: 32984360 DOI: 10.3389/fmed.2020.00410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bailey SER, Abel GA, Atkins A, Byford R, Davies SJ, Mays J, McDonald TJ, Miller J, Neck C, Renninson J, Thomas P, Walter FM, Warren S, Hamilton W. Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England. Br J Cancer 2021;124:1231-6. [PMID: 33462361 DOI: 10.1038/s41416-020-01221-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Burton JK, Yates LC, Whyte L, Fitzsimons E, Stott DJ. New horizons in iron deficiency anaemia in older adults. Age Ageing 2020;49:309-18. [PMID: 32103233 DOI: 10.1093/ageing/afz199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Widlak MM, Neal M, Daulton E, Thomas CL, Tomkins C, Singh B, Harmston C, Wicaksono A, Evans C, Smith S, Savage RS, Covington JA, Arasaradnam RP. Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers. Colorectal Dis. 2018;20:O335-O342. [PMID: 30248228 DOI: 10.1111/codi.14431] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
15 Maclean W, Singh R, Mackenzie P, White D, Benton S, Stebbing J, Rockall T, Jourdan I. The two-week rule colorectal cancer pathway: an update on recent practice, the unsustainable burden on diagnostics and the role of faecal immunochemical testing. Ann R Coll Surg Engl 2020;102:308-11. [PMID: 32081023 DOI: 10.1308/rcsann.2020.0019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
16 Laszlo HE, Seward E, Ayling RM, Lake J, Malhi A, Stephens C, Pritchard-Jones K, Chung D, Hackshaw A, Machesney M. Faecal immunochemical test for patients with 'high-risk' bowel symptoms: a large prospective cohort study and updated literature review. Br J Cancer 2021. [PMID: 34903843 DOI: 10.1038/s41416-021-01653-x] [Reference Citation Analysis]
17 Navarro M, Hijos G, Ramirez T, Omella I, Carrera-Lasfuentes P, Lanas Á. Fecal Hemoglobin Concentration, a Good Predictor of Risk of Advanced Colorectal Neoplasia in Symptomatic and Asymptomatic Patients. Front Med (Lausanne) 2019;6:91. [PMID: 31131279 DOI: 10.3389/fmed.2019.00091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
18 Rodriguez-Alonso L, Rodriguez-Moranta F, Arajol C, Gilabert P, Serra K, Martin A, Ibáñez-Sanz G, Moreno V, Guardiola J. Proton pump inhibitors reduce the accuracy of faecal immunochemical test for detecting advanced colorectal neoplasia in symptomatic patients. PLoS One 2018;13:e0203359. [PMID: 30169524 DOI: 10.1371/journal.pone.0203359] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
19 Loktionov A, Soubieres A, Bandaletova T, Francis N, Allison J, Sturt J, Mathur J, Poullis A. Biomarker measurement in non-invasively sampled colorectal mucus as a novel approach to colorectal cancer detection: screening and triage implications. Br J Cancer 2020;123:252-60. [PMID: 32398859 DOI: 10.1038/s41416-020-0893-8] [Reference Citation Analysis]
20 D'Souza N, Georgiou Delisle T, Chen M, Benton S, Abulafi M;  NICE FIT Steering Group. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study. Gut. 2020;. [PMID: 33087488 DOI: 10.1136/gutjnl-2020-321956] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
21 D'Souza N, Delisle TG, Chen M, Benton SC, Abulafi M; NICE FIT Steering Committee . Faecal immunochemical testing in symptomatic patients to prioritize investigation: diagnostic accuracy from NICE FIT Study. Br J Surg 2021;108:804-10. [PMID: 33755051 DOI: 10.1093/bjs/znaa132] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Ayling RM, Lewis SJ, Cotter F. Potential roles of artificial intelligence learning and faecal immunochemical testing for prioritisation of colonoscopy in anaemia. Br J Haematol 2019;185:311-6. [PMID: 30714125 DOI: 10.1111/bjh.15776] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
23 Digby J, Steele RJ, Strachan JA, Mowat C, Anderson AS, Mccann R, Law L, Fraser CG. Do other variables add value to assessment of the risk of colorectal disease using faecal immunochemical tests for haemoglobin? Ann Clin Biochem 2019;56:472-9. [DOI: 10.1177/0004563219839423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
24 Maclean W, Limb C, Mackenzie P, Whyte MB, Benton SC, Rockall T, Jourdan I. Adoption of faecal immunochemical testing for 2‐week‐wait colorectal patients during the COVID‐19 pandemic: an observational cohort study reporting a new service at a regional centre. Colorectal Dis 2021;23:1622-9. [DOI: 10.1111/codi.15408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Fraser CG. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges. Surgeon. 2018;16:302-308. [PMID: 29548552 DOI: 10.1016/j.surge.2018.01.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
26 Gachabayov M, Lebovics E, Rojas A, Felsenreich DM, Latifi R, Bergamaschi R. Performance evaluation of stool DNA methylation tests in colorectal cancer screening: a systematic review and meta-analysis. Colorectal Dis 2021;23:1030-42. [PMID: 33410272 DOI: 10.1111/codi.15521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Steele RJC, Fraser CG. Faecal Immunochemical Tests (FIT) for Haemoglobin for Timely Assessment of Patients with Symptoms of Colorectal Disease. In: Olsson L, editor. Timely Diagnosis of Colorectal Cancer. Cham: Springer International Publishing; 2018. pp. 39-66. [DOI: 10.1007/978-3-319-65286-3_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
28 Maclean W, Zahoor Z, O'Driscoll S, Piggott C, Whyte MB, Rockall T, Jourdan I, Benton SC. Comparison of the QuikRead go® point-of-care faecal immunochemical test for haemoglobin with the FOB Gold Wide® laboratory analyser to diagnose colorectal cancer in symptomatic patients. Clin Chem Lab Med 2022;60:101-8. [PMID: 34679264 DOI: 10.1515/cclm-2021-0655] [Reference Citation Analysis]
29 Maclean W, Mackenzie P, Limb C, Zahoor Z, Whyte MB, Rockall T, Benton SC, Jourdan I. Diagnostic accuracy of point of care faecal immunochemical testing using a portable high-speed quantitative analyser for diagnosis in 2-week wait patients. Colorectal Dis 2021;23:2376-86. [PMID: 34157205 DOI: 10.1111/codi.15780] [Reference Citation Analysis]
30 Maeda Y, Gray E, Figueroa JD, Hall PS, Weller D, Dunlop MG, Din FVN. Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing. BJS Open 2021;5:zrab056. [PMID: 34228096 DOI: 10.1093/bjsopen/zrab056] [Reference Citation Analysis]
31 Hamarneh Z, Symonds EL, Kholmurodova F, Cock C. Older age, symptoms, or anemia: Which factors increase colorectal cancer risk with a positive fecal immunochemical test? J Gastroenterol Hepatol 2020;35:1002-8. [PMID: 31606908 DOI: 10.1111/jgh.14888] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Fernández-Bañares F, Clèries R, Boadas J, Ribes J, Oliva JC, Alsius A, Sanz X, Martínez-Bauer E, Galter S, Pujals M, Pujol M, Del Pozo P, Campo R. Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study).BMC Cancer. 2019;19:734. [PMID: 31345180 DOI: 10.1186/s12885-019-5926-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
33 Westwood M, Lang S, Armstrong N, van Turenhout S, Cubiella J, Stirk L, Ramos IC, Luyendijk M, Zaim R, Kleijnen J, Fraser CG. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance. BMC Med. 2017;15:189. [PMID: 29061126 DOI: 10.1186/s12916-017-0944-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 11.8] [Reference Citation Analysis]
34 von Wagner C, Stoffel S, Freeman M, Laszlo H, Nicholson BD, Sheringham J, Szinay D, Hirst Y. Attitudes towards faecal immunochemical testing in patients at increased risk of colorectal cancer: an online survey of GPs in England. Br J Gen Pract 2018;68:e757-64. [PMID: 30297435 DOI: 10.3399/bjgp18X699413] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
35 D'Souza N, Hicks G, Benton SC, Abulafi M. The diagnostic accuracy of the faecal immunochemical test for colorectal cancer in risk-stratified symptomatic patients. Ann R Coll Surg Engl 2020;102:174-9. [PMID: 31697171 DOI: 10.1308/rcsann.2019.0144] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
36 van Melle M, Yep Manzano SIS, Wilson H, Hamilton W, Walter FM, Bailey SER. Faecal immunochemical test to triage patients with abdominal symptoms for suspected colorectal cancer in primary care: review of international use and guidelines. Fam Pract 2020;37:606-15. [PMID: 32377668 DOI: 10.1093/fampra/cmaa043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
37 Von Wagner C, Stoffel ST, Freeman M, Laszlo HE, Nicholson BD, Sheringham J, Szinay D, Hirst Y. General practitioners' awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey. BMJ Open 2019;9:e025737. [PMID: 30975679 DOI: 10.1136/bmjopen-2018-025737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]